Intuitive Surgical Inc Stock
Intuitive Surgical Inc Stock
There is an upward development for Intuitive Surgical Inc compared to yesterday, with an increase of €4.10 (1.280%).
With 75 Buy predictions and 2 Sell predictions Intuitive Surgical Inc is one of the favorites of our community.
With a target price of 507 € there is a hugely positive potential of 56.14% for Intuitive Surgical Inc compared to the current price of 324.7 €.
Our community identified positive and negative aspects for Intuitive Surgical Inc stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Intuitive Surgical Inc stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Intuitive Surgical Inc in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Intuitive Surgical Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc | 1.280% | -7.900% | 3.637% | -22.232% | -34.458% | 21.924% | 7.416% |
| Veeva Systems A | -0.330% | -1.963% | 24.140% | -11.972% | 12.115% | 24.898% | -21.671% |
| Boston Scientific | 2.270% | -5.718% | 10.159% | -53.527% | -48.047% | -8.384% | 11.377% |
| Waters Corp. | 0.520% | -3.344% | 10.728% | 36.160% | 5.796% | 40.976% | 0.814% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2025-04-26
INTUITIVE SURGICAL INC (ISRG) demonstrates a strong financial position as of Q2 2025. Key findings include: - Revenue growth: $2,253.4 million in Q2 2025 vs. $1,890.6 million in Q2 2024, representing a 19.2% increase - Net income growth: $698.4 million in Q2 2025 vs. $544.9 million in Q2 2024, representing a 28.2% increase - Strong cash position: $7,657.8 million in total current assets as of March 31, 2025 - The overall financial trend is positive, driven by revenue growth and improving profitability.
Investors should consider these factors when evaluating ISRG, focusing on the company's ability to continue its growth trajectory while managing potential risks.
Comments
Intuitive Surgical (ISRG) had its "overweight" rating reaffirmed by Piper Sandler.
Show more
Ratings data for ISRG provided by MarketBeat
Intuitive Surgical (ISRG) had its "overweight" rating reaffirmed by KeyCorp.
Show more
Ratings data for ISRG provided by MarketBeat
Intuitive Surgical (ISRG) had its "outperform" rating reaffirmed by Sanford C. Bernstein.
Show more
Ratings data for ISRG provided by MarketBeat